Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori.

about

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori.

Item

http://www.wikidata.org/entity/Q40101139

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Adding Bismuth to Rabeprazole- ...... cation of Helicobacter pylori.

@en

type

Item

label

Adding Bismuth to Rabeprazole- ...... cation of Helicobacter pylori.

@en

prefLabel

Adding Bismuth to Rabeprazole- ...... cation of Helicobacter pylori.

@en

P1476

Adding Bismuth to Rabeprazole- ...... ication of Helicobacter pylori

@en

P2093

Fang-Jung Yu

http://www.w3.org/2001/XMLSchema#string

Fu-Chen Kuo

http://www.w3.org/2001/XMLSchema#string

Meng-Chieh Wu

http://www.w3.org/2001/XMLSchema#string

Min-Li Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Bismuth therapy in gastrointestinal diseases

Antibiotic resistance problems with Helicobacter pylori.

Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.

Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia

Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.

Review article: the global emergence of Helicobacter pylori antibiotic resistance.

Helicobacter pylori treatment in the era of increasing antibiotic resistance.

P304

5320180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/5320180

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28791044

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

5534286

http://www.w3.org/2001/XMLSchema#string